ghk-cu peptide injection sites Dosage and Protocol: The 30-Day Cycle FDA scientists flag concerns with

PMID 12446535

The elevated B12 appears to be a consequence of disease activity, likely resulting from increased production of B12-binding proteins by tumor cells or from liver involvement in the cancer process

RE: Mesocycle Progression in Hypertrophy: Volume Versus Intensity

Until rigorous studies show that BPC-157 does not awaken any sleeping dragons (like micrometastases), its best viewed with deep skepticism

There are many potentially useful biomarkers presently proposed making them difficult to prioritize

Usually mild and associated with higher doses or administration timing (such as on an empty stomach that triggers sensitivity in some individuals)